Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nano-propolis is a nanoparticle-based formulation of propolis, a natural resinous substance collected by honeybees from various plant sources. Developed and investigated by researchers at Cairo University, it is being evaluated as an endodontic irrigant for the treatment of necrotic mature teeth associated with periapical periodontitis. Propolis contains a complex mixture of bioactive compounds, including flavonoids, phenolic acids, and esters, which confer broad-spectrum antimicrobial, anti-inflammatory, and antioxidant properties. The nano-formulation is specifically designed to enhance the penetration of these active constituents into the complex root canal anatomy and dentinal tubules, improving the disinfection of the root canal system. This enhanced disinfection is a critical step in regenerative endodontic procedures (revascularization), aimed at promoting the healing of periapical tissues and the potential regeneration of the pulp-dentin complex.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nano-propolis.